SCHEMBL8105677

SCHEMBL8105677

CCOc1nc(OCC)n(Cc2ccc(Cc3cccc(C(=O)O)c3)cc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 5/20 0.46
TP53 P04637 5/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
PKM P14618 2/20 0.46
NFKB1 P19838 2/20 0.46
NFKB2 Q00653 2/20 0.46
RELA Q04206 2/20 0.46
MDM2 Q00987 3/20 0.43
YTHDC1 Q96MU7 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
HTT P42858 1/20 0.40
IDO1 P14902 1/20 0.39
TDO2 P48775 1/20 0.39
KMT2A Q03164 1/20 0.39
RAB9A P51151 2/20 0.38
POLB P06746 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8111259 0.90 TP53 (0.46) MRGPRX4TP53SMN1; SMN2PKMNFKB1
SCHEMBL8109471 0.89 PLA2G4B (0.42) MRGPRX4TP53SMN1; SMN2PKMNFKB1
SCHEMBL8105171 0.87 PPARG (0.48) MRGPRX4SMN1; SMN2RAB9ANPC1
SCHEMBL8096048 0.82 IDO1 (0.41) MRGPRX4SMN1; SMN2YTHDC1CA1CA2
SCHEMBL8096066 0.82 TSHR (0.46) CA1CA2CA9KMT2A
SCHEMBL8103519 0.77 PPARG (0.49) MRGPRX4TP53SMN1; SMN2MDM2KMT2A
SCHEMBL8105267 0.76 PPARG (0.48)
SCHEMBL6005872 0.76 AGTR1 (0.52)
SCHEMBL9737993 0.74 KMT2A (0.47) SMN1; SMN2KMT2APOLB
SCHEMBL8105656 0.73 PPARG (0.47) SMN1; SMN2YTHDC1CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3098772-B2 2000-10-16 JP claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP claimed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed